These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9879834)

  • 41. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
    Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methotrexate uptake by psoriatic epidermis.
    Taylor JR; Halprin KM
    Br J Dermatol; 1977 Feb; 96(2):167-70. PubMed ID: 320999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells.
    Jolivet J; Faure MP; Wong SC; Taub JW; Matherly LH
    Br J Cancer; 1997; 76(6):734-8. PubMed ID: 9310238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of reduced folate carrier in intestinal folate uptake.
    Balamurugan K; Said HM
    Am J Physiol Cell Physiol; 2006 Jul; 291(1):C189-93. PubMed ID: 16495369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity.
    Peltonen J; Karvonen SL; Ylä-Outinen H; Hirvonen O; Karvonen J
    J Invest Dermatol; 1995 Nov; 105(5):664-7. PubMed ID: 7594640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
    Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.
    Bruch-Gerharz D; Fehsel K; Suschek C; Michel G; Ruzicka T; Kolb-Bachofen V
    J Exp Med; 1996 Nov; 184(5):2007-12. PubMed ID: 8920887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Despite some expression of folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated.
    Khokhar NZ; Lam AF; Rusch VW; Sirotnak FM
    J Thorac Cardiovasc Surg; 2002 May; 123(5):862-8. PubMed ID: 12019370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced folate carrier-mediated methotrexate transport in human distal lung epithelial NCl-H441 cells.
    Kawami M; Honda N; Miyamoto M; Yumoto R; Takano M
    J Pharm Pharmacol; 2019 Feb; 71(2):167-175. PubMed ID: 30324648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition.
    Deng Y; Hou Z; Wang L; Cherian C; Wu J; Gangjee A; Matherly LH
    Mol Pharmacol; 2008 Apr; 73(4):1274-81. PubMed ID: 18182479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
    Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility.
    Zhao R; Wang Y; Gao F; Goldman ID
    Biochim Biophys Acta; 2003 Jun; 1613(1-2):49-56. PubMed ID: 12832086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis.
    Henno A; Blacher S; Lambert C; Colige A; Seidel L; Noël A; Lapière C; de la Brassinne M; Nusgens BV
    Br J Dermatol; 2009 Mar; 160(3):581-90. PubMed ID: 18945297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
    Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
    J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclophilin content of normal and psoriatic epidermis.
    Griffiths CE; Fisher GJ; Harding MW; Elder JT; Voorhees JJ
    J Invest Dermatol; 1990 Apr; 94(4):436-40. PubMed ID: 2179418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carrier-mediated membrane transport of folates in mammalian cells.
    Sirotnak FM; Tolner B
    Annu Rev Nutr; 1999; 19():91-122. PubMed ID: 10448518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
    Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.